Literature DB >> 20949587

A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors.

Richard Shaffer1, Emily Vollans, Rosie Vellani, Margaret Welsh, Vitali Moiseenko, Karen Goddard.   

Abstract

BACKGROUND: This planning study compared RapidArc, fixed-field IMRT (cIMRT), 3D conformal radiotherapy (3D-CRT), and a parallel-opposed pair (POP) for children with retroperitoneal tumors. PROCEDURE: Plans were generated in eight patients to treat the PTV (dose range 19.8-45 Gy) while limiting kidney and liver doses. In selected patients, vertebral body (VB) dose heterogeneity was minimized. Cumulative DVH parameters, monitor units (MU), and treatment times were compared for the four techniques using the Wilcoxon matched pairs test.
RESULTS: RapidArc and cIMRT covered target volumes more conformally than 3D-CRT and POP (P = 0.012). There was no difference in the ability to meet kidney dose constraints. A significantly lower volume of the liver received 12 Gy with cIMRT or RapidArc compared with 3D-CRT (P = 0.028). Where VB was included in PTV, VB dose homogeneity was generally within 94-104% of the prescription dose. Time to deliver a single fraction with RapidArc, POP, 3D-CRT, and cIMRT was 1.25 ± 0.01, 1.38 ± 0.10, 2.6 ± 0.45, and 4.02 ± 1.12 min, respectively (P = 0.012). Monitor units for a single fraction with POP, 3D-CRT, RapidArc, and cIMRT were 203 ± 26, 235 ± 32, 325 ± 71, and 665 ± 215, respectively (P < 0.05).
CONCLUSIONS: POP resulted in favorable MU, treatment time and dosimetry but had poor conformality. 3D-CRT was more conformal but had higher MU and treatment time. RapidArc and cIMRT were generally no better dosimetrically than conformal techniques. RapidArc was dosimetrically very similar to cIMRT, but resulted in a major reduction in time and MU used to deliver the radiation.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20949587     DOI: 10.1002/pbc.22649

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.

Authors:  Anne Ducassou; Marion Gambart; Caroline Munzer; Laetitia Padovani; Christian Carrie; Daphne Haas-Kogan; Valérie Bernier-Chastagner; Charlotte Demoor; Line Claude; Sylvie Helfre; Stéphanie Bolle; Julie Leseur; Aymeri Huchet; Hervé Rubie; Dominique Valteau-Couanet; Gudrun Schleiermacher; Carole Coze; Anne-Sophie Defachelles; Aurélien Marabelle; Stéphane Ducassou; Christine Devalck; Virginie Gandemer; Martine Munzer; Anne Laprie
Journal:  Strahlenther Onkol       Date:  2015-04-21       Impact factor: 3.621

3.  Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.

Authors:  Emmanuel Jouglar; Antoine Wagner; Grégory Delpon; Loïc Campion; Philippe Meingan; Valérie Bernier; Charlotte Demoor-Goldschmidt; Marc-André Mahé; Thomas Lacornerie; Stéphane Supiot
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

4.  Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma.

Authors:  Li Zhang; Mian Xi; Xiao-Wu Deng; Qiao-Qiao Li; Xiao-Yan Huang; Meng-Zhong Liu
Journal:  J Radiat Res       Date:  2012-06-28       Impact factor: 2.724

5.  Comparison of the dosimetries of 3-dimensions Radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma.

Authors:  Violaine Beneyton; Claudine Niederst; Céline Vigneron; Philippe Meyer; François Becmeur; Luc Marcellin; Patrick Lutz; Georges Noel
Journal:  BMC Med Phys       Date:  2012-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.